Prolonged Time to Adjuvant Chemotherapy Initiation Was Associated with Worse Disease Outcome in Triple Negative Breast Cancer Patients
出版年份 2020 全文链接
标题
Prolonged Time to Adjuvant Chemotherapy Initiation Was Associated with Worse Disease Outcome in Triple Negative Breast Cancer Patients
作者
关键词
-
出版物
Scientific Reports
Volume 10, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-04-27
DOI
10.1038/s41598-020-64005-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- ER+/HER2+ Breast Cancer Has Different Metastatic Patterns and Better Survival Than ER−/HER2+ Breast Cancer
- (2019) Cletus A. Arciero et al. Clinical Breast Cancer
- Does time to adjuvant chemotherapy (TTC) affect outcomes in patients with triple-negative breast cancer?
- (2019) Maria K. Pomponio et al. BREAST CANCER RESEARCH AND TREATMENT
- Timing and Delays in Breast Cancer Evaluation and Treatment
- (2018) Richard J. Bleicher ANNALS OF SURGICAL ONCOLOGY
- Impact of timeliness of adjuvant chemotherapy and radiotherapy on the outcomes of breast cancer; a pooled analysis of three clinical trials
- (2018) Omar Abdel-Rahman BREAST
- Update on the Treatment of Early-Stage Triple-Negative Breast Cancer
- (2018) Priyanka Sharma CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Risk Factors for Delays in Adjuvant Chemotherapy Following Immediate Breast Reconstruction
- (2018) Oriana Cohen et al. PLASTIC AND RECONSTRUCTIVE SURGERY
- The effect of delayed adjuvant chemotherapy on relapse of triple-negative breast cancer
- (2018) Shuang Li et al. Journal of Thoracic Disease
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Paclitaxel With Inhibitor of Apoptosis Antagonist, LCL161, for Localized Triple-Negative Breast Cancer, Prospectively Stratified by Gene Signature in a Biomarker-Driven Neoadjuvant Trial
- (2018) Aditya Bardia et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of dysregulated miRNAs in triple negative breast cancer: A meta-analysis approach
- (2018) Leimarembi Devi Naorem et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Delays in Diagnosis and Treatment of Breast Cancer: A Safety-Net Population Profile
- (2018) Kshama Jaiswal et al. Journal of the National Comprehensive Cancer Network
- Timely initiation of chemotherapy: a systematic literature review of six priority cancers - results and recommendations for clinical practice
- (2017) M. Alexander et al. INTERNAL MEDICINE JOURNAL
- Long-Term Follow-Up of the Intergroup Exemestane Study
- (2017) James P. Morden et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular alterations in triple-negative breast cancer—the road to new treatment strategies
- (2017) Carsten Denkert et al. LANCET
- 11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial
- (2017) David Cameron et al. LANCET
- Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer
- (2017) Gunter von Minckwitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Factors Associated With Delays in Chemotherapy Initiation Among Patients With Breast Cancer at a Comprehensive Cancer Center
- (2016) Katya Losk et al. Journal of the National Comprehensive Cancer Network
- Influence of delayed initiation of adjuvant chemotherapy on breast cancer survival is subtype-dependent
- (2016) Ke-Da Yu et al. Oncotarget
- Delayed Initiation of Adjuvant Chemotherapy Among Patients With Breast Cancer
- (2016) Mariana Chavez-MacGregor et al. JAMA Oncology
- Clinical Impact of Delaying Initiation of Adjuvant Chemotherapy in Patients With Breast Cancer
- (2014) Debora de Melo Gagliato et al. JOURNAL OF CLINICAL ONCOLOGY
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
- (2013) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Association between delayed initiation of adjuvant CMF or anthracycline-based chemotherapy and survival in breast cancer: a systematic review and meta-analysis
- (2013) Ke-Da Yu et al. BMC CANCER
- Time to Begin Adjuvant Chemotherapy and Survival in Breast Cancer Patients: A Retrospective Observational Study Using Latent Class Analysis
- (2013) Amy Downing et al. Breast Journal
- Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
- (2013) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant chemotherapy in luminal breast cancers
- (2011) Elgene Lim et al. BREAST
- Association Between Time to Initiation of Adjuvant Chemotherapy and Survival in Colorectal Cancer
- (2011) James J. Biagi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Classical Cyclophosphamide, Methotrexate, and Fluorouracil Chemotherapy Is More Effective in Triple-Negative, Node-Negative Breast Cancer: Results From Two Randomized Trials of Adjuvant Chemoendocrine Therapy for Node-Negative Breast Cancer
- (2010) Marco Colleoni et al. JOURNAL OF CLINICAL ONCOLOGY
- Delays in Adjuvant Chemotherapy Treatment Among Patients With Breast Cancer Are More Likely in African American and Hispanic Populations: A National Cohort Study 2004-2006
- (2010) Stacey A. Fedewa et al. JOURNAL OF CLINICAL ONCOLOGY
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search